Cargando…

Vaccinating Women Previously Exposed to Human Papillomavirus: A Cost-Effectiveness Analysis of the Bivalent Vaccine

Recent trials have indicated that women with prior exposure to Human papillomavirus (HPV) subtypes 16/18 receive protection against reinfection from the HPV vaccines. However, many of the original models investigating the cost effectiveness of different vaccination strategies for the protection of c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Turner, Hugo C., Baussano, Iacopo, Garnett, Geoff P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3784449/ https://www.ncbi.nlm.nih.gov/pubmed/24086567 http://dx.doi.org/10.1371/journal.pone.0075552

Ejemplares similares

Human Papillomavirus Vaccination at a Time of Changing Sexual Behavior
por: Baussano, Iacopo, et al.
Publicado: (2016)

Impacts of human papillomavirus vaccination for different populations: A modeling study
por: Baussano, Iacopo, et al.
Publicado: (2018)

Potential health impact and cost-effectiveness of bivalent human papillomavirus (HPV) vaccination in Afghanistan
por: Anwari, Palwasha, et al.
Publicado: (2020)

Cost-Effectiveness Analysis of the Bivalent and Quadrivalent Human Papillomavirus Vaccines from a Societal Perspective in Colombia
por: Aponte-González, Johanna, et al.
Publicado: (2013)

Vaccination With Moderate Coverage Eradicates Oncogenic Human Papillomaviruses If a Gender-Neutral Strategy Is Applied
por: Vänskä, Simopekka, et al.
Publicado: (2020)

Human papillomavirus vaccine coverage in Rwanda: A population-level analysis by birth cohort
por: Sayinzoga, Felix, et al.
Publicado: (2020)

Upscaling human papillomavirus vaccination in high-income countries: impact assessment based on transmission model
por: Baussano, Iacopo, et al.
Publicado: (2014)

Impact of Human Papillomavirus Vaccination, Rwanda and Bhutan
por: Baussano, Iacopo, et al.
Publicado: (2021)

Vaccinating women previously treated for human papillomavirus-related cervical precancerous lesions is highly cost-effective in China
por: Zou, Maosheng, et al.
Publicado: (2023)

Early effect of bivalent human papillomavirus vaccination on cytology outcomes in cervical samples among young women in the Netherlands
por: Schurink‐van ’t Klooster, Tessa M., et al.
Publicado: (2023)

Comparing bivalent and quadrivalent human papillomavirus vaccines: economic evaluation based on transmission model
por: Jit, Mark, et al.
Publicado: (2011)

Human papillomavirus vaccine effect against human papillomavirus infection in Rwanda: evidence from repeated cross-sectional cervical-cell-based surveys
por: Sayinzoga, Felix, et al.
Publicado: (2023)

Bivalent Human Papillomavirus (HPV) Vaccine Effectiveness Correlates With Phylogenetic Distance From HPV Vaccine Types 16 and 18
por: Bogaards, Johannes A, et al.
Publicado: (2019)

Human papillomavirus infection in Bhutan at the moment of implementation of a national HPV vaccination programme
por: Tshomo, Ugyen, et al.
Publicado: (2014)

Human papillomavirus infection in Rwanda at the moment of implementation of a national HPV vaccination programme
por: Ngabo, Fidele, et al.
Publicado: (2016)

Bivalent Human Papillomavirus Vaccine Effectiveness in a Japanese Population: High Vaccine-Type–Specific Effectiveness and Evidence of Cross-Protection
por: Kudo, Risa, et al.
Publicado: (2019)

Neutralization of non-vaccine human papillomavirus pseudoviruses from the A7 and A9 species groups by bivalent HPV vaccine sera
por: Draper, Eve, et al.
Publicado: (2011)

Effect of bivalent human papillomavirus vaccination on pregnancy outcomes: long term observational follow-up in the Costa Rica HPV Vaccine Trial
por: Panagiotou, Orestis A, et al.
Publicado: (2015)

Cost-effectiveness of human papillomavirus vaccination in Germany
por: Damm, Oliver, et al.
Publicado: (2017)

Costs of delivering human papillomavirus vaccination in Tanzania
por: Struckmann, V, et al.
Publicado: (2022)

Health and economic effects of introducing single-dose or two-dose human papillomavirus vaccination in India
por: M de Carvalho, Tiago, et al.
Publicado: (2023)

Cost-Effectiveness of Bivalent, Quadrivalent, and Nonavalent HPV Vaccination in South Africa
por: Michaeli, Daniel Tobias, et al.
Publicado: (2022)

Immunogenicity of Bivalent Human Papillomavirus DNA Vaccine Using Human Endogenous Retrovirus Envelope-Coated Baculoviral Vectors in Mice and Pigs
por: Lee, Hee-Jung, et al.
Publicado: (2012)

Cost-effectiveness of Human Papillomavirus Vaccination in the United States
por: Chesson, Harrell W., et al.
Publicado: (2008)

Cost Effectiveness of a Potential Vaccine for Human papillomavirus
por: Sanders, Gillian D., et al.
Publicado: (2003)

Cost-effectiveness of different human papillomavirus vaccines in Singapore
por: Lee, Vernon J, et al.
Publicado: (2011)

The Cost-Effectiveness of Quadrivalent Human Papillomavirus Vaccination in Indonesia
por: Kosen, Soewarta, et al.
Publicado: (2017)

Cost of a human papillomavirus vaccination project, Zimbabwe
por: Hidle, Anna, et al.
Publicado: (2018)

Human papillomavirus (HPV) in young women in Britain: Population-based evidence of the effectiveness of the bivalent immunisation programme and burden of quadrivalent and 9-valent vaccine types
por: Tanton, Clare, et al.
Publicado: (2017)

Evidence-based impact projections of single-dose human papillomavirus vaccination in India: a modelling study
por: Man, Irene, et al.
Publicado: (2022)

Risk of miscarriage with bivalent vaccine against human papillomavirus (HPV) types 16 and 18: pooled analysis of two randomised controlled trials
por: Wacholder, Sholom, et al.
Publicado: (2010)

Cost-Effectiveness Analysis of Human Papillomavirus Vaccination in Adolescent Girls in Taiwan
por: Tang, Chao-Hsiun, et al.
Publicado: (2019)

Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis
por: Drolet, Mélanie, et al.
Publicado: (2021)

Options for design of real-world impact studies of single-dose vaccine schedules
por: Franceschi, Silvia, et al.
Publicado: (2018)

Cervical cancer risk perceptions, sexual risk behaviors and sexually transmitted infections among Bivalent Human Papillomavirus vaccinated and non-vaccinated young women in Uganda - 5 year follow up study
por: Kumakech, Edward, et al.
Publicado: (2017)

Human papillomavirus vaccine
por: Singhal, Priyanka, et al.
Publicado: (2009)

Cost-effectiveness of bivalent versus monovalent vaccines against hand, foot and mouth disease
por: Liu, D., et al.
Publicado: (2019)

Vaccine Effectiveness Following Routine Immunization With Bivalent Human Papillomavirus (HPV) Vaccine: Protection Against Incident Genital HPV Infections From a Reduced-Dosing Schedule
por: Hoes, Joske, et al.
Publicado: (2021)

Human papillomavirus vaccine effectiveness by age at first vaccination among Japanese women
por: Onuki, Mamiko, et al.
Publicado: (2022)

Prevention is life- and cost-saving
por: Baussano, Iacopo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ea1260ogb3epe0uufb22lv0saq